🇺🇸 FDA
Patent

US 6153200

Vaccine compositions and methods useful in inducing immune protection against arthritogenic peptides involved in the pathogenesis of rheumatoid arthritis

expired A61KA61K38/1841A61K39/00

Quick answer

US patent 6153200 (Vaccine compositions and methods useful in inducing immune protection against arthritogenic peptides involved in the pathogenesis of rheumatoid arthritis) held by The Regents of the University of California expires Mon Nov 23 2020 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Nov 28 2000 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 23 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K38/1841, A61K39/00, A61K39/0008, A61K39/40